Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Cash Flow Quality Index
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Cash Flow Quality Index of -0.20x as of June 2023. Operating cash flow of €-64.53 Million is below net income of €321.70 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Tianjin Zhong Xin Pharmaceutical Group C to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Tianjin Zhong Xin Pharmaceutical Group C (2TZ) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year earnings quality comparison for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. For live market cap and the full company financial profile, see 2TZ market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | €461.07 Million | €2.13 Billion | ▼ -47.8% |
| 2024 | 0.41x | €924.67 Million | €2.23 Billion | ▼ -40.6% |
| 2023 | 0.70x | €688.49 Million | €986.71 Million | ▼ -11.2% |
| 2022 | 0.79x | €677.25 Million | €861.79 Million | ▼ -29.1% |
| 2021 | 1.11x | €852.40 Million | €769.14 Million | ▲ +9.2% |
| 2020 | 1.01x | €671.42 Million | €661.70 Million | ▲ +28.1% |
| 2019 | 0.79x | €495.49 Million | €625.57 Million | ▲ +27.1% |
| 2018 | 0.62x | €350.14 Million | €561.68 Million | ▲ +7570.7% |
| 2017 | -0.01x | €-3.97 Million | €476.08 Million | ▼ -100.8% |
| 2016 | 0.99x | €417.77 Million | €422.42 Million | ▲ +23.8% |
| 2015 | 0.80x | €360.58 Million | €451.44 Million | ▼ -0.4% |
| 2014 | 0.80x | €286.85 Million | €357.80 Million | ▲ +32.1% |
| 2013 | 0.61x | €213.44 Million | €351.79 Million | — |